• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡:脓毒症和急性呼吸窘迫综合征的新角色。

Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome.

机构信息

Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.

Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

Front Cell Infect Microbiol. 2022 Apr 7;12:853840. doi: 10.3389/fcimb.2022.853840. eCollection 2022.

DOI:10.3389/fcimb.2022.853840
PMID:35463634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9021632/
Abstract

Sepsis refers to a complex syndrome associated with physiological, pathological, and biochemical abnormalities resulted from infection. Sepsis is the major cause of acute respiratory distress syndrome (ARDS). Extracellular vesicles (EVs) are serving as new messengers to mediate cell-cell communication . Non-coding RNAs, proteins and metabolites encapsulated by EVs could result in either pro-inflammatory or anti-inflammatory effects in the recipient cells. Pathogens or host cells derived EVs play an important role in pathogens infection during the occurrence and development of sepsis and ARDS. Additionally, we summarize the potential application for EVs in diagnosis, prevention and treatment for sepsis and ARDS.

摘要

脓毒症是一种与感染引起的生理、病理和生化异常相关的复杂综合征。脓毒症是急性呼吸窘迫综合征(ARDS)的主要病因。细胞外囊泡(EVs)作为新的信使,介导细胞间通讯。EVs 包裹的非编码 RNA、蛋白质和代谢物可在受体细胞中产生促炎或抗炎作用。病原体或宿主细胞衍生的 EVs 在脓毒症和 ARDS 的发生和发展过程中病原体感染中发挥重要作用。此外,我们总结了 EVs 在脓毒症和 ARDS 的诊断、预防和治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b233/9021632/19be2a0565e2/fcimb-12-853840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b233/9021632/8acd201bc9f0/fcimb-12-853840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b233/9021632/19be2a0565e2/fcimb-12-853840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b233/9021632/8acd201bc9f0/fcimb-12-853840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b233/9021632/19be2a0565e2/fcimb-12-853840-g002.jpg

相似文献

1
Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome.细胞外囊泡:脓毒症和急性呼吸窘迫综合征的新角色。
Front Cell Infect Microbiol. 2022 Apr 7;12:853840. doi: 10.3389/fcimb.2022.853840. eCollection 2022.
2
Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome.细胞外囊泡:急性呼吸窘迫综合征研究的新前沿。
Am J Respir Cell Mol Biol. 2020 Jul;63(1):15-24. doi: 10.1165/rcmb.2019-0447TR.
3
Circulating extracellular vesicles are associated with the clinical outcomes of sepsis.循环细胞外囊泡与脓毒症的临床结局相关。
Front Immunol. 2023 Apr 25;14:1150564. doi: 10.3389/fimmu.2023.1150564. eCollection 2023.
4
Endothelial cell-derived extracellular vesicles expressing surface VCAM1 promote sepsis-related acute lung injury by targeting and reprogramming monocytes.内皮细胞来源的表达表面 VCAM1 的细胞外囊泡通过靶向和重编程单核细胞促进脓毒症相关的急性肺损伤。
J Extracell Vesicles. 2024 Mar;13(3):e12423. doi: 10.1002/jev2.12423.
5
CD14-positive extracellular vesicles in bronchoalveolar lavage fluid as a new biomarker of acute respiratory distress syndrome.支气管肺泡灌洗液中 CD14 阳性细胞外囊泡作为急性呼吸窘迫综合征的一种新生物标志物。
Am J Physiol Lung Cell Mol Physiol. 2022 Apr 1;322(4):L617-L624. doi: 10.1152/ajplung.00052.2022. Epub 2022 Mar 2.
6
Role of extracellular vesicles in severe pneumonia and sepsis.细胞外囊泡在重症肺炎和脓毒症中的作用。
Expert Opin Biol Ther. 2022 Jun;22(6):747-762. doi: 10.1080/14712598.2022.2066470. Epub 2022 Apr 16.
7
Extracellular vesicles in acute respiratory distress syndrome: Recent developments from bench to bedside.急性呼吸窘迫综合征中的细胞外囊泡:从实验台到临床的最新进展
Int Immunopharmacol. 2021 Nov;100:108118. doi: 10.1016/j.intimp.2021.108118. Epub 2021 Sep 1.
8
Extracellular vesicles participate in the pathogenesis of sepsis.细胞外囊泡参与脓毒症的发病机制。
Front Cell Infect Microbiol. 2022 Dec 12;12:1018692. doi: 10.3389/fcimb.2022.1018692. eCollection 2022.
9
Endothelial Cell-Derived Extracellular Vesicles Promote Aberrant Neutrophil Trafficking and Subsequent Remote Lung Injury.内皮细胞衍生的细胞外囊泡促进异常中性粒细胞迁移和随后的远处肺损伤。
Adv Sci (Weinh). 2024 Oct;11(38):e2400647. doi: 10.1002/advs.202400647. Epub 2024 Aug 9.
10
Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment.间充质干细胞来源的细胞外囊泡:急性呼吸窘迫综合征治疗的一种潜在生物药物。
BioDrugs. 2022 Nov;36(6):701-715. doi: 10.1007/s40259-022-00555-5. Epub 2022 Sep 10.

引用本文的文献

1
Adipose-derived mesenchymal stem cell-derived extracellular vesicles carry microRNA-214-3p to target GSTZ1 to curb ferroptosis in lung epithelial cells during sepsis.脂肪来源的间充质干细胞衍生的细胞外囊泡携带微小RNA-214-3p靶向谷胱甘肽硫转移酶Z1,以抑制脓毒症期间肺上皮细胞的铁死亡。
Cytotechnology. 2025 Aug;77(4):132. doi: 10.1007/s10616-025-00793-9. Epub 2025 Jul 1.
2
Antibiotic treatment modulates -derived bacterial extracellular vesicle (BEV) production and their capacity to upregulate ICAM-1 in human endothelial cells.抗生素治疗可调节源自细菌的细胞外囊泡(BEV)的产生及其上调人内皮细胞中细胞间黏附分子-1(ICAM-1)的能力。
bioRxiv. 2025 May 13:2025.05.12.653517. doi: 10.1101/2025.05.12.653517.
3

本文引用的文献

1
Calming egress of inflammatory monocytes and related septic shock by therapeutic CCR2 silencing using macrophage-derived extracellular vesicles.利用巨噬细胞衍生的细胞外囊泡进行 CCR2 沉默的治疗性干预,以缓解炎症性单核细胞的流出并改善相关的脓毒性休克。
Nanoscale. 2022 Mar 31;14(13):4935-4945. doi: 10.1039/d1nr06922e.
2
Mechanism and Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells for the Treatment of Infectious Diseases.间充质干细胞衍生的细胞外囊泡治疗感染性疾病的机制与潜力
Front Microbiol. 2021 Oct 26;12:761338. doi: 10.3389/fmicb.2021.761338. eCollection 2021.
3
Functional delivery of lncRNA TUG1 by endothelial progenitor cells derived extracellular vesicles confers anti-inflammatory macrophage polarization in sepsis via impairing miR-9-5p-targeted SIRT1 inhibition.
Predicting mortality and risk factors of sepsis related ARDS using machine learning models.
使用机器学习模型预测脓毒症相关急性呼吸窘迫综合征的死亡率及风险因素。
Sci Rep. 2025 Apr 18;15(1):13509. doi: 10.1038/s41598-025-96501-w.
4
Global trends in research on endothelial cells and sepsis between 2002 and 2022: A systematic bibliometric analysis.2002年至2022年间内皮细胞与脓毒症研究的全球趋势:一项系统的文献计量分析。
Heliyon. 2023 Dec 12;10(1):e23599. doi: 10.1016/j.heliyon.2023.e23599. eCollection 2024 Jan 15.
5
Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation.细胞外囊泡介导的针对抗原特异性呈递的免疫反应的调节
Vaccines (Basel). 2022 Oct 10;10(10):1691. doi: 10.3390/vaccines10101691.
内皮祖细胞衍生的外泌体递送长链非编码 RNA TUG1 可通过抑制 miR-9-5p 靶向的 SIRT1 抑制来实现脓毒症中抗炎型巨噬细胞极化。
Cell Death Dis. 2021 Nov 6;12(11):1056. doi: 10.1038/s41419-021-04117-5.
4
Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects.基于细胞外囊泡的COVID-19治疗:前景、挑战与未来展望
Biomedicines. 2021 Oct 1;9(10):1373. doi: 10.3390/biomedicines9101373.
5
Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis.长链非编码 RNA 作为脓毒症的生物标志物和治疗靶点。
Front Immunol. 2021 Sep 22;12:722004. doi: 10.3389/fimmu.2021.722004. eCollection 2021.
6
Extracellular vesicles in acute respiratory distress syndrome: Recent developments from bench to bedside.急性呼吸窘迫综合征中的细胞外囊泡:从实验台到临床的最新进展
Int Immunopharmacol. 2021 Nov;100:108118. doi: 10.1016/j.intimp.2021.108118. Epub 2021 Sep 1.
7
Extracellular Vesicles: A Double-Edged Sword in Sepsis.细胞外囊泡:脓毒症中的双刃剑
Pharmaceuticals (Basel). 2021 Aug 23;14(8):829. doi: 10.3390/ph14080829.
8
Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.细胞外囊泡在脓毒症治疗中的治疗潜力
Adv Ther (Weinh). 2021 Jul;4(7). doi: 10.1002/adtp.202000259. Epub 2021 Apr 29.
9
Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis.糖皮质激素抵抗合并高乳酸血症导致脓毒症致死性休克。
Cell Metab. 2021 Sep 7;33(9):1763-1776.e5. doi: 10.1016/j.cmet.2021.07.002. Epub 2021 Jul 23.
10
Acute respiratory distress syndrome.急性呼吸窘迫综合征。
Lancet. 2021 Aug 14;398(10300):622-637. doi: 10.1016/S0140-6736(21)00439-6. Epub 2021 Jul 1.